Laparoscopic surgery has a fast evolution during the last decades and is being performed for increasingly complex surgical procedures. Despite increasing recognition of the benefits of this approach, the majority of pancreatic surgeons remain uncertain about the advantages of this technique1,2,3,4,5. Laparoscopic distal pancreatectomy is now proven to be safe and readily available, although its use in the treatment of adenocarcinoma is still debated2,4,6,7. Since the first report on laparoscopic pancreatoduodenectomy (LPD) in 19948, few studies have described the technique9,10,11,12. Non-randomized studies reported a reduction in delayed gastric emptying and in the estimated intraoperative blood loss has been reported for LPD, as compared to open pancreatoduodenectomy13,14. One randomized trial and a systematic review reported that LPD could reduce a hospital stay, without increasing the overall costs15,16. Unfortunately, LPD seems to be associated with higher rates of postoperative pancreatic fistula and readmission, especially in low volume centers17. The best pancreatic anastomosis technique is still open for debate. The most common anastomoses performed during open pancreatoduodenectomy are being reproduced in LPD. However, as for open pancreatic surgery, the results obtained with LPD are controversial. Safety, feasibility, reproducibility and simplicity of the pancreatic anastomosis have a crucial role in the diffusion of this technique and in its surgical results.
The Blumgart pancreatic anastomosis is a simple and effective technique that combines the principle of duct-to-mucosa anastomosis with jejunal covering over the raw surface of the pancreas18. The Blumgart anastomosis has been associated with lower pancreatic fistula rate to than the other techniques19.
This article aims to demonstrate the safety and feasibility of LPD and specifically the pancreaticojejunostomy (PJ) with a modified Blumgart anastomosis and its surgical oncologic outcome in a patient with an ampullary tumor.